Elaine Marie Hylek, MD, MPH
November 28th, 2011
Roundtable: Two Trials, Two Anticoagulants, Many Implications
Samuel Goldhaber, MD, Elaine Marie Hylek, MD, MPH and Christian Thomas Ruff, MD, MPH
Three experts weigh in on findings from the ATLAS ACS 2-TIMI 51 and ADOPT trials.
March 18th, 2011
Dabigatran Dialogue: Two Experts Answer Our Questions and Yours
Samuel Goldhaber, MD and Elaine Marie Hylek, MD, MPH
In a series of blog posts on CardioExchange, Samuel Goldhaber, Director of the Venous Thromboembolism Research Group in the Cardiovascular Division at Brigham and Women’s Hospital, has been guiding us on best practices around dabigatran. Recently, he teamed up with Elaine Hylek, Director of the Thrombosis and Anticoagulation Service at Boston University School of Medicine, […]
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?